216 related articles for article (PubMed ID: 12562963)
1. Analysis of the differential modulation of sulphonylurea block of beta-cell and cardiac ATP-sensitive K+ (K(ATP)) channels by Mg-nucleotides.
Reimann F; Dabrowski M; Jones P; Gribble FM; Ashcroft FM
J Physiol; 2003 Feb; 547(Pt 1):159-68. PubMed ID: 12562963
[TBL] [Abstract][Full Text] [Related]
2. Tissue specificity of sulfonylureas: studies on cloned cardiac and beta-cell K(ATP) channels.
Gribble FM; Tucker SJ; Seino S; Ashcroft FM
Diabetes; 1998 Sep; 47(9):1412-8. PubMed ID: 9726229
[TBL] [Abstract][Full Text] [Related]
3. Involvement of the n-terminus of Kir6.2 in coupling to the sulphonylurea receptor.
Reimann F; Tucker SJ; Proks P; Ashcroft FM
J Physiol; 1999 Jul; 518 ( Pt 2)(Pt 2):325-36. PubMed ID: 10381582
[TBL] [Abstract][Full Text] [Related]
4. Altered functional properties of KATP channel conferred by a novel splice variant of SUR1.
Sakura H; Trapp S; Liss B; Ashcroft FM
J Physiol; 1999 Dec; 521 Pt 2(Pt 2):337-50. PubMed ID: 10581306
[TBL] [Abstract][Full Text] [Related]
5. Sulfonylurea receptors type 1 and 2A randomly assemble to form heteromeric KATP channels of mixed subunit composition.
Chan KW; Wheeler A; Csanády L
J Gen Physiol; 2008 Jan; 131(1):43-58. PubMed ID: 18079561
[TBL] [Abstract][Full Text] [Related]
6. The Kir6.2-F333I mutation differentially modulates KATP channels composed of SUR1 or SUR2 subunits.
Tammaro P; Ashcroft F
J Physiol; 2007 Jun; 581(Pt 3):1259-69. PubMed ID: 17395632
[TBL] [Abstract][Full Text] [Related]
7. Effect of repaglinide on cloned beta cell, cardiac and smooth muscle types of ATP-sensitive potassium channels.
Dabrowski M; Wahl P; Holmes WE; Ashcroft FM
Diabetologia; 2001 Jun; 44(6):747-56. PubMed ID: 11440368
[TBL] [Abstract][Full Text] [Related]
8. Identification of the high-affinity tolbutamide site on the SUR1 subunit of the K(ATP) channel.
Ashfield R; Gribble FM; Ashcroft SJ; Ashcroft FM
Diabetes; 1999 Jun; 48(6):1341-7. PubMed ID: 10342826
[TBL] [Abstract][Full Text] [Related]
9. Differential nucleotide regulation of KATP channels by SUR1 and SUR2A.
Masia R; Enkvetchakul D; Nichols CG
J Mol Cell Cardiol; 2005 Sep; 39(3):491-501. PubMed ID: 15893323
[TBL] [Abstract][Full Text] [Related]
10. Taurine block of cloned ATP-sensitive K+ channels with different sulfonylurea receptor subunits expressed in Xenopus laevis oocytes.
Lim JG; Lee HY; Yun JE; Kim SP; Park JW; Suh SI; Jang BC; Cho CH; Bae JH; Kim SS; Han J; Park MJ; Song DK
Biochem Pharmacol; 2004 Sep; 68(5):901-10. PubMed ID: 15294453
[TBL] [Abstract][Full Text] [Related]
11. HMR 1098 is not an SUR isotype specific inhibitor of heterologous or sarcolemmal K ATP channels.
Zhang HX; Akrouh A; Kurata HT; Remedi MS; Lawton JS; Nichols CG
J Mol Cell Cardiol; 2011 Mar; 50(3):552-60. PubMed ID: 21185839
[TBL] [Abstract][Full Text] [Related]
12. Nateglinide, a D-phenylalanine derivative lacking either a sulfonylurea or benzamido moiety, specifically inhibits pancreatic beta-cell-type K(ATP) channels.
Chachin M; Yamada M; Fujita A; Matsuoka T; Matsushita K; Kurachi Y
J Pharmacol Exp Ther; 2003 Mar; 304(3):1025-32. PubMed ID: 12604678
[TBL] [Abstract][Full Text] [Related]
13. Sensitivity of Kir6.2-SUR1 currents, in the absence and presence of sodium azide, to the K(ATP) channel inhibitors, ciclazindol and englitazone.
McKay NG; Kinsella JM; Campbell CM; Ashford ML
Br J Pharmacol; 2000 Jun; 130(4):857-66. PubMed ID: 10864893
[TBL] [Abstract][Full Text] [Related]
14. Potent and selective activation of the pancreatic beta-cell type K(ATP) channel by two novel diazoxide analogues.
Dabrowski M; Larsen T; Ashcroft FM; Bondo Hansen J; Wahl P
Diabetologia; 2003 Oct; 46(10):1375-82. PubMed ID: 12961066
[TBL] [Abstract][Full Text] [Related]
15. Role of the C-terminus of SUR in the differential regulation of β-cell and cardiac K
Vedovato N; Rorsman O; Hennis K; Ashcroft FM; Proks P
J Physiol; 2018 Dec; 596(24):6205-6217. PubMed ID: 30179258
[TBL] [Abstract][Full Text] [Related]
16. Three C-terminal residues from the sulphonylurea receptor contribute to the functional coupling between the K(ATP) channel subunits SUR2A and Kir6.2.
Dupuis JP; Revilloud J; Moreau CJ; Vivaudou M
J Physiol; 2008 Jul; 586(13):3075-85. PubMed ID: 18450778
[TBL] [Abstract][Full Text] [Related]
17. Sulfonylureas suppress the stimulatory action of Mg-nucleotides on Kir6.2/SUR1 but not Kir6.2/SUR2A KATP channels: a mechanistic study.
Proks P; de Wet H; Ashcroft FM
J Gen Physiol; 2014 Nov; 144(5):469-86. PubMed ID: 25348414
[TBL] [Abstract][Full Text] [Related]
18. Glimepiride block of cloned beta-cell, cardiac and smooth muscle K(ATP) channels.
Song DK; Ashcroft FM
Br J Pharmacol; 2001 May; 133(1):193-9. PubMed ID: 11325810
[TBL] [Abstract][Full Text] [Related]
19. The interaction of nucleotides with the tolbutamide block of cloned ATP-sensitive K+ channel currents expressed in Xenopus oocytes: a reinterpretation.
Gribble FM; Tucker SJ; Ashcroft FM
J Physiol; 1997 Oct; 504 ( Pt 1)(Pt 1):35-45. PubMed ID: 9350615
[TBL] [Abstract][Full Text] [Related]
20. The effects of mitiglinide (KAD-1229), a new anti-diabetic drug, on ATP-sensitive K+ channels and insulin secretion: comparison with the sulfonylureas and nateglinide.
Sunaga Y; Gonoi T; Shibasaki T; Ichikawa K; Kusama H; Yano H; Seino S
Eur J Pharmacol; 2001 Nov; 431(1):119-25. PubMed ID: 11716850
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
